10.9K
Downloads
522
Episodes
CFRI's CF Community Voices is a video podcast series created by and for the cystic fibrosis community.
Episodes
Dec 9, 2020
Dec 9, 2020
58 min
The role of anti-inflammatories in CF care is vital. Lenabasum, Corbus Pharmaceuticals' investigational drug that mimics the effects of endocannabinoids in regulating inflammation, has been tracked through the clinical trial process with tremendous optimism. Dr. Chmiel, Principal Investigator of CF-002 (lenabasum), and Division Chief for Pediatric Pulmonology, Allergy and Sleep Medicine at Indiana University School of Medicine, reviews the results of the recent Phase IIb trial, and its implications for the CF community.
Sponsored by Vertex Pharmaceuticals, Gilead Sciences, Chiesi USA, Genentech, and Viatris, with additional support from Corbus Pharmaceuticals.
Jun 25, 2020
Jun 25, 2020
7 min
We thank Vertex Pharmaceuticals, Gilead Sciences, Genentech, Chiesi USA, and Mylan Pharmaceuticals for their support of these podcasts.
Jun 24, 2020
Jun 24, 2020
57 min
Rick Moss, MD, CF clinician and researcher at Stanford, answers CF and COVID-19-related questions submitted by our community over the past week related to antibody tests, impacts on those with CF, and much more. This session was recorded on June 24, 2020.
We thank Vertex Pharmaceuticals, Gilead Sciences, Genentech, and Chiesi USA for their support of these podcasts.
Track: Woods Artist: Federico Fabbiano Music provided by Oak Studios https://youtu.be/eAiAlg22gqQ
May 27, 2020
May 27, 2020
46 min
Rick Moss, MD, CF clinician and researcher at Stanford, answers CF and COVID-19-related questions submitted by our community over the past week related to antibody tests, impacts on those with CF, and much more. This final session was recorded on May 27, 2020.
We thank Vertex Pharmaceuticals, Gilead Sciences, Genentech, and Chiesi USA for their support of these podcasts.
Track: Woods Artist: Federico Fabbiano Music provided by Oak Studios https://youtu.be/eAiAlg22gqQ
May 20, 2020
May 20, 2020
48 min
Rick Moss, MD, CF clinician and researcher at Stanford, answers CF and COVID-19-related questions submitted by our community over the past week related to antibody tests, impacts on those with CF, and much more. Please feel free to submit additional questions by email to sreveles@cfri.org. This session was recorded on May 20, 2020.
We thank Vertex Pharmaceuticals, Gilead Sciences, Genentech, and Chiesi USA for their support of these podcasts.
Track: Woods Artist: Federico Fabbiano Music provided by Oak Studios https://youtu.be/eAiAlg22gqQ
May 13, 2020
May 13, 2020
45 min
Rick Moss, MD, CF clinician and researcher at Stanford, answers CF and COVID-19-related questions submitted by our community over the past week related to antibody tests, impacts on those with CF, and much more. Please feel free to submit additional questions by email to sreveles@cfri.org. This most recent session was recorded on May 13, 2020.
We thank Vertex Pharmaceuticals, Gilead Sciences, Genentech, and Chiesi USA for their support of these podcasts.
Track: Woods Artist: Federico Fabbiano Music provided by Oak Studios https://youtu.be/eAiAlg22gqQ
May 6, 2020
May 6, 2020
49 min
Rick Moss, MD, CF clinician and researcher at Stanford, answers CF and COVID-19-related questions submitted by our community over the past week related to antibody tests, impacts on those with CF, and much more. Dr. Moss has generously offered to continue these Q&A sessions to keep us informed. Please feel free to submit additional questions by email to cfri@cfri.org. This most recent session was recorded on May 6, 2020.
We thank Vertex Pharmaceuticals, Gilead Sciences, Genentech, and Chiesi USA for their support of these podcasts.
Apr 29, 2020
Apr 29, 2020
53 min
Rick Moss, MD, CF clinician and researcher at Stanford, answers CF and COVID-19-related questions submitted by our community over the past week related to antibody tests, impacts on those with CF, and much more. Dr. Moss has generously offered to continue these Q&A sessions to keep us informed. Please feel free to submit additional questions by email to cfri@cfri.org. This most recent session was recorded on April 29, 2020.
We thank Vertex Pharmaceuticals, Gilead Sciences, Genentech, and Chiesi USA for their support of these podcasts.
Apr 28, 2020
Apr 28, 2020
1hr 54 sec
Dr. Vinayak Jha, Physician of Pulmonary and Critical Care Medicine at the Adult CF center at California Pacific Medical Center in San Francisco, discusses the impact of cystic fibrosis upon bone health. Those with CF have high rates of osteopenia and osteoporosis, often occurring at a very young age. In this podcast, Dr. Jha discusses the reasons behind this and available interventions to maintain bone health.
CF Community Voices is generously sponsored by Vertex Pharmaceuticals, Genentech, Chiesi USA, and Gilead Sciences.
Apr 28, 2020
Apr 28, 2020
1hr 54 sec
Dr. Vinayak Jha, Physician of Pulmonary and Critical Care Medicine at the Adult CF center at California Pacific Medical Center in San Francisco, discusses the impact of cystic fibrosis upon bone health. Those with CF have high rates of osteopenia and osteoporosis, often occurring at a very young age. In this podcast, Dr. Jha discusses the reasons behind this and available interventions to maintain bone health.
CF Community Voices is generously sponsored by Vertex Pharmaceuticals, Genentech, Chiesi USA, and Gilead Sciences.